{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT03823391: Phase 2 Interventional Completed Rheumatoid Arthritis (RA)
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03410901: Phase 1 Interventional Active, not recruiting B-Cell Non-Hodgkin Lymphoma
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03577028: Phase 1/Phase 2 Interventional Terminated Advanced Prostate Cancer
(2018)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01891669: Phase 1 Interventional Terminated Neoplasms
(2013)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04641871: Phase 1 Interventional Active, not recruiting Metastatic Cancer
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03801915: Phase 2 Interventional Completed Colon Cancer
(2019)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02674763: Phase 1 Interventional Completed Acute Myeloid Leukemia
(2016)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02529553: Phase 1 Interventional Completed Advanced Cancer
(2015)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03118349: Phase 1 Interventional Terminated Pancreatic Carcinoma
(2017)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02864290: Phase 1 Interventional Terminated Acute Myeloid Leukemia
(2016)
Source URL:
Class:
CONCEPT